Bruker’s market-leading MALDI Biotyper (MBT) is the globally recognised solution for routine microbial identification.
The company is continuously adding workflows based on the MBT, including MBT Sepsityper for direct identification from positive blood culture, and MBT STAR-BL assays for resistance testing.
Bruker also market IR Biotyper for strain typing targeting hygiene management, and MICRONAUT for antimicrobial susceptibility testing of bacteria and yeasts.
Bruker’s molecular testing portfolio comprises assays for virology, mycobacteria and TB testing among other PCR assays and systems. Your SARS-CoV-2 diagnostic workflow can be simplified by automated extraction using the GenoXtract fleXT. The renowned FluoroCycler XT, with simple, intuitive software, is easy to use and generates reliable and easy-to-interpret results for assays such as Bruker’s FluoroType SARS-CoV-2 product line.